Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two.
Haibel, Hildrun 1; Rudwaleit, Martin 1; Listing, Joachim 2; Heldmann, Frank 3; Wong, Robert L. 4; Kupper, Hartmut 5; Braun, Jurgen 3; Sieper, Joachim 6
Arthritis & Rheumatism.
58(7):1981-1991, July 2008.
(Format: HTML, PDF)